Sulfonylureas

Integrated Control on Residual Damage of Persistent Sulfonylureas in Soil

长残效磺酰脲类除草剂土壤残留危害的综合治理技术研究

Determination and prediction of partition coefficient for sulfonylureas and their main degradation products

磺酰脲类除草剂及其主要降解产物分配系数的测定与预测

Clinical effect of Human insulin in secondary failure of sulfonylureas

人胰岛素在磺脲类药物继发失效中的疗效观察

Clinic Analysis of 20 Cases with Severe Hypoglycemia Caused by Sulfonylureas

磺（酰）脲类药物致严重低血糖20例临床分析

Progress about the effects of sulfonylureas on islet β cells apoptosis

磺脲类药物对胰岛β细胞凋亡影响的研究进展

Characteristics of Sulfonylureas Chemicals and Status Quo of Research at Home and Abroad of Monitoring Technology

磺酰脲类农药特性及国内外监测技术研究现状

Continuous glucose monitoring in subjects with secondary sulfonylureas failure

动态血糖仪监测继发性磺脲类失效血糖漂移的特点

Clinical Observation on Secondary Inefficiency of Sulfonylureas Drugs for Diabetes Based on Spleen

中药治疗2型糖尿病口服磺脲类降糖药继发性失效

Change of Serum Leptin Level in Type 2 Diabetics with Secondary Failure to Sulfonylureas

磺脲类降糖药继发性失效2型糖尿病患者血清瘦素水平的变化

A study on the safety and injury of sulfonylureas herbicides to cereal crops

磺酰脲类除草剂对禾谷类作物的安全性及药害研究

Belongs to the class of medicines called sulfonylureas .

属于磺脲类口服降糖药。

Short-term intensive insulin treatment and sensitivity of sulfonylureas

胰岛素短期强化治疗恢复磺脲类降糖药敏感性30例的效果分析

Different Therapeutic Regimens for Diabetic Patients with Sulfonylureas Secondary Failure : Cost-Effectiveness Analyses and Evaluation of Life Quality

磺脲类药物继发失效患者不同治疗方案的成本-效果及对生存质量的影响

Effect of chronic hyperglycemia on islet β cells function in type 2 diabetes mellitus with secondary sulfonylureas failure

长期高血糖对继发磺脲类药物失效患者胰岛β细胞功能的影响

Effect of treatment and change of islet function by adding insulin glargine on patients with second failure of sulfonylureas

磺脲类继发失效糖尿病患者加用胰岛素疗效及胰岛B细胞功能变化

Studies of Mechanisms of Amylin on Insulin Release from Rat Pancreatic β Cells and Sulfonylureas Secondary Failure

胰淀素对大鼠胰岛β细胞分泌胰岛素及磺脲类药物继发失效机制的研究

A Study on insulin release and peripheral sensitivity in non-insulin dependent diabetic with secondary failure to sulfonylureas

继发性磺脲类失效糖尿病患者胰岛素释放及外周胰岛素敏感度的研究

Objective To research the effects of short-term intensive insulin treatment on regaining the sensitivity of sulfonylureas in diabetes patients .

目的探讨胰岛素短期强化治疗恢复糖尿患者对磺脲类药物的敏感性。

Therapeutic effect of pioglitazone hydrochloride in type 2 diabetic patients poorly controlled with metformin and sulfonylureas

盐酸吡格列酮对磺脲类和双胍类药物联合治疗失效的2型糖尿病患者的疗效观察

Evaluation of Determination Results from 3 Kinds of Hematology Analyzers Continuous glucose monitoring in subjects with secondary sulfonylureas failure

三种血细胞分析仪检测结果比较分析动态血糖仪监测继发性磺脲类失效血糖漂移的特点

Effects of Chinese Medicinal Injection Plus Catgut Implantation at Acupoint on Diabetics with Secondary Sulfonylureas Failure

经穴强化埋线联合中药注入治疗磺脲类药物继发失效机理的研究

Sulfonylureas are rarely used in kids because they cause weight gain and hypoglycemia is a much bigger problem than in adults .

磺酰脲类药物可引起体重增加，而且低血糖对于孩子而言要比对成人更为棘手，故该药很少用于孩子。

Study on QSAR of Its Hypoglycemic Activity of 3-Bromine Coumarin Sulfonylureas

3-溴香豆素磺酰脲类化合物降血糖活性的定量构效关系研究

It is a drug that 's well studied in adults , safe , and now costs no more than generic oral sulfonylureas .

该药已在成人中得到充分的研究，安全性好，且费用也不高于通用名药磺酰脲类口服药。

An independent epidemiological study found that users of sulfonylureas were at higher risk of cancer-related mortality than metformin users ( 7 ) .

一项独立进行的流行病学研究发现，使用磺脲类药物的患者癌症死亡率高于使用二甲双胍的患者。

Clinical Observation on Secondary Inefficiency of Sulfonylureas Drugs for Diabetes Based on Spleen COMBINATION THERAPY WITH INSULIN FOR FAILURE FOLLOWING SULFONYLUREA THERAPY IN DIABETES

从脾论治磺脲类降糖药继发性失效胰岛素联合用药治疗磺脲类继发性失效临床观察

Nonlinear QSAR studies of herbicidal sulfonylureas and sulfonamides

磺酰脲（胺）类除草剂的非线性QSAR研究

Conclusion Pioglitazone may improve blood glucose level that in type 2 diabetic patients uncontrolled with metformin in combination with sulfonylureas and increase insulin sensitivity .

结论盐酸吡格列酮可改善磺脲类和双胍类药物联合治疗血糖仍未达标的2型糖尿病患者的血糖水平，提高胰岛素敏感性。

Except acarbose causing stomach and intestinal system injured , the rest ADR was mainly caused by sulfonylureas ( SUs ) .

抗DM药物的ADR以代谢和营养障碍、神经系统损害、精神紊乱、胃肠系统损害为主，其中除胃肠系统损害主要由阿卡波糖引起外，其余以磺酰脲类占绝大多数；

In general , the sulfonylureas , thiazolidinediones , and D-phenylalanine derivatives have been shown to promote weight gain .

总体而言，磺脲类，噻唑烷二酮类以及苯丙氨酸派生物被证实可促进对体重的增加。